Pharmacare steps in budget ‘waste of money,’ ‘meaningless’ if they don’t cover all Canadians: academics
By Samantha Wright AllenMar. 27, 2019
Observers are divided on the creation of a national drug agency, with some saying it’s a good first step, while the NDP critic says it’s ‘reorganization, not progress.’
The 2019 budget's funding to build a new Canadian Drug Agency represents 'concrete steps towards national pharmacare,' according to the office of Health Minister Ginette Petitpas Taylor. The Hill Times photograph by Andrew Meade
The Liberal plan outlined in this year’s budget to launch a new drug agency amounts to another delay on pharmacare, according to NDP health critic Don Davies, while others say it represents a small first step forward.
People. Policy. Politics. This is an exclusive subscriber-only story.
Going Green Key players, committee meetings, debates, highlights from Question Period, press releases on Bill C-45, The Cannabis Act, as well as stories on the topic. Get the book
The federal response to the opioid crisis Summarizes the work on the opioid crisis that is going on at the federal level: what the House of Commons and the Senate have been listening to and acting on to help stop and mitigate this tragedy. Get the book
Hill Times Research The daily tracking service for Health Industry Professionals. Curated health news and analysis. Get the research
Politics This Morning
Your email has been added. An email has been sent to your address, please click the link inside of it to confirm your subscription.
Some employees have no designated desks, leaving little space for personal belongings or accessibility accommodations, say critics. But the government says the change is meant to design workspaces around client departmen